<code id='0DEBFEA0F3'></code><style id='0DEBFEA0F3'></style>
    • <acronym id='0DEBFEA0F3'></acronym>
      <center id='0DEBFEA0F3'><center id='0DEBFEA0F3'><tfoot id='0DEBFEA0F3'></tfoot></center><abbr id='0DEBFEA0F3'><dir id='0DEBFEA0F3'><tfoot id='0DEBFEA0F3'></tfoot><noframes id='0DEBFEA0F3'>

    • <optgroup id='0DEBFEA0F3'><strike id='0DEBFEA0F3'><sup id='0DEBFEA0F3'></sup></strike><code id='0DEBFEA0F3'></code></optgroup>
        1. <b id='0DEBFEA0F3'><label id='0DEBFEA0F3'><select id='0DEBFEA0F3'><dt id='0DEBFEA0F3'><span id='0DEBFEA0F3'></span></dt></select></label></b><u id='0DEBFEA0F3'></u>
          <i id='0DEBFEA0F3'><strike id='0DEBFEA0F3'><tt id='0DEBFEA0F3'><pre id='0DEBFEA0F3'></pre></tt></strike></i>

          knowledge

          knowledge

          author:hotspot    Page View:5
          Two business miniatures talk to each other on coin stacks that are sandwiched by a syringe and a stethoscope — coverage from STAT
          Adobe

          For all the flak they get, the country’s four biggest pharmacy benefit managers reported a surprisingly tame average profit margin in the first three quarters of 2023: 4.5%, less than a third of their drugmaker peers.

          But don’t take their numbers as gospel, experts warned.

          advertisement

          “It’s really easy to move money around inside the books of a vertically integrated organization,” said Karen Van Nuys, a senior fellow at the USC Schaeffer Center for Health Policy and Economics. “If one segment of your vertically integrated organization is not publishing any financial data, it’s a good place to hide stuff.”

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          Wikipedia

          Anesthesiologist group: stop taking Ozempic before surgery
          Anesthesiologist group: stop taking Ozempic before surgery

          EspeciallyinthefirstweeksoftakingdrugslikeOzempic,foodstayslongerinthestomach—aprobleminsurgeries.Ad

          read more
          In early work, researchers turn to CRISPR to treat Alzheimer's
          In early work, researchers turn to CRISPR to treat Alzheimer's

          AdobeWhenthegenome-editingtoolCRISPRisthoughtofasapotentialmedicine,thetargetsthatfirstcometomindare

          read more
          Drug repurposing or repositioning? The language matters
          Drug repurposing or repositioning? The language matters

          AdobeFindinganewmedicineisnevereasy.Butdevelopingtreatmentsforpatientswithrarediseases—conditionstha

          read more

          Key House panel plots a new health care package

          CommitteechairmanRep.JasonSmith(R-Mo.)speakswithrankingmemberRep.RichardNeal(D-Mass.).DrewAngerer/Ge